VCEL 8-K 2026-11-05

Vericel Corp (VCEL) 8-K dated 2026-11-05 — accession 0001628280-26-070622.

Vericel Corp (VCEL) is a biotechnology company listed on US.

Vericel Corp filed a 8-K on 2026-11-05. Accession 0001628280-26-070622.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported VCEL revenue for 2025-12-31 was $276.3M. Net income was $16.5M. Revenue was up 16.5% from 2024-12-31 to 2025-12-31. VCEL currently screens at market cap $2.10B.

Not investment advice. The VCEL SEC hub lists recent forms. The stock page is the research view.